Fukuda R, Nagasawa-Fujimori H
J Biol Chem. 1983 Feb 25;258(4):2720-8.
The mechanism of the rifampicin induction of RNA polymerase beta and beta' subunit synthesis was investigated, employing an in vitro coupled system of transcription and translation as well as an in vitro transcription system with purified RNA polymerase holoenzyme. Two independent effects leading to the induction of beta and beta' polypeptide synthesis have been identified for the drug: 1) rifampicin binds to RNA polymerase holoenzyme and inhibits its autorepressor activity, thus relieving the autorepression exerted possibly on the translation of rpoBC mRNA; and 2) rifampicin-RNA polymerase complex functions as a positive effector stimulating the transcription of rpoBC genes, but not of rplL gene. Using a terminally labeled DNA fragment covering the intercistronic region between rplL and rpoB as a probe, the structure of both in vivo and in vitro RNA were analyzed by S1 nuclease-mapping assays. The experimental results indicated that the observed stimulation of the transcription by rifampicin was attributed, at least in part, to relaxation of the transcription attenuation immediately preceding the rpoB gene, resulting in the increase of the read-through transcript to rpoBC genes. Besides the read-through transcript and the processed mature rpoBC mRNA, another RNA species was found in in vivo RNA, which might be transcribed from a weak promoter located in the intercistronic region. However, no clear indication has been obtained of possible enhancement of the transcription initiation by rifampicin from the putative promoter.
利用体外转录和翻译偶联系统以及纯化的RNA聚合酶全酶体外转录系统,研究了利福平诱导RNA聚合酶β和β'亚基合成的机制。已确定该药物对β和β'多肽合成的诱导有两种独立作用:1)利福平与RNA聚合酶全酶结合并抑制其自身阻遏物活性,从而解除可能对rpoBC mRNA翻译施加的自身阻遏;2)利福平-RNA聚合酶复合物作为一种正效应物刺激rpoBC基因的转录,但不刺激rplL基因的转录。使用覆盖rplL和rpoB之间基因间区域的末端标记DNA片段作为探针,通过S1核酸酶图谱分析体内和体外RNA的结构。实验结果表明,观察到的利福平对转录的刺激至少部分归因于rpoB基因之前转录衰减的缓解,导致rpoBC基因通读转录本增加。除了通读转录本和加工后的成熟rpoBC mRNA外,在体内RNA中还发现了另一种RNA物种,它可能是从位于基因间区域的一个弱启动子转录而来。然而,尚未获得利福平从推定启动子增强转录起始的明确证据。